Interventional firm Cook has completed patient enrollment in the STARZ-TX2 (Study of Thoracic Aortic Aneurysm Repair with Zenith TX2 Thoracic TAA endovascular graft) clinical trial.
The Bloomington, IN-based firm is preparing data for submission to the U.S. Food and Drug Administration (FDA) later this year. The trial enrolled more than 200 patients at 39 clinical sites around the world.
By AuntMinnie.com staff writers
August 1, 2006
Related Reading
Cook gets FDA OK on central venous catheter, July 25, 2006
Cook nets FDA nod, July 6, 2006
Cook Med Institute expands, June 29, 2006
Cook launches MRI-safe embolization coil, March 31, 2006
Cook reports success with retrievable vena cava filter, December 6, 2006
Copyright © 2006 AuntMinnie.com
